Steptoe Therapeutics Inc Information

Steptoe Therapeutics, Inc. (STI) is an early stage small biotech company engaged in the development of therapies for infertility patients. STI is initially focused in repositioning existing approved pharmaceutical products in new infertility indications. Our lead product candidate STI2832 is indicated for treating a condition caused by a fertility drug. Steptoe Therapeutics is preparing for a pre-IND meeting with the FDA to discuss the development of STI2832. The company has recently secured intellectual property for the use of a cytokine in ovulation induction (US Patent 8,183,205B2). Steptoe Therapeutics Inc. is based in Hingham, Massachussetts 20 miles south of Boston. The company is small and it plans to stay small developing it's product candidates with private funding using a very small footprint company model. STI associated company BMT Management, LLC has been distributing medical products and equipment in reproductive medicine since 2003. The company is operating as Steptoe Medical Devices in the US.